908 Devices Inc. (MASS) Stock Price & Analysis
908 Devices Inc. (MASS) fell 1.36% to USD 7.99 as of June 10, 2026 at 02:23 UTC, according to Nexqual real-time market data.
MASS last closed at USD 8.1; the session ranged USD 7.6–8.37 on volume of 206,289 shares. Market capitalization is $302.13M, with a 52-week range of USD 5.03–9.34 (NGM). Source: Nexqual, June 10, 2026 at 02:23 UTC.
Key Statistics (as of June 10, 2026 at 02:23 UTC)
| Price | USD 7.99 |
|---|---|
| Change | ▼ 1.36% (down) |
| Previous Close | USD 8.1 |
| Open | USD 8.17 |
| Day Range | USD 7.6 – 8.37 |
| 52-Week Range | USD 5.03 – 9.34 |
| Volume | 206,289 shares |
| Market Cap | $302.13M |
| Exchange | NGM |
Technical Analysis (MASS)
Nexqual's technical model rates MASS "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 02:23 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 52.18 (neutral) |
| vs SMA50 | Above (USD 7.34) |
| MACD | 0.31 (positive) |
Analyst Ratings (MASS)
Wall Street analysts rate MASS "None" based on 2 analysts, with a mean price target of USD 11 (range USD 10–12), per Nexqual as of June 10, 2026 at 02:23 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 11 |
| High Target | USD 12 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (MASS)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD -0.14 |
| Revenue Estimate | $15.42M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.07 vs est -0.14 ▲ beat |
| 2025-12-31 | USD 0.02 vs est -0.06 ▲ beat |
| 2025-09-30 | USD -0.04 vs est -0.12 ▲ beat |
| 2025-06-30 | USD -0.26 vs est -0.15 ▼ miss |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Financials & Fundamentals (MASS)
| Total Revenue | $57.80M |
|---|---|
| Revenue Growth (YoY) | +13.60% |
| Gross Margin | +52.01% |
| Operating Margin | -48.60% |
| Profit Margin | -62.40% |
| ROE | -24.11% |
| Debt / Equity | 3.33 |
| Current Ratio | 3.58 |
| Total Cash | $111.74M |
| Total Debt | $4.47M |
| Free Cash Flow | $13.74M |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Financial Health Score (MASS)
Nexqual rates 908 Devices Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:23 UTC.
| Growth | Weak — Revenue -6% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 52%, operating -49% |
| Balance Sheet | Strong — $112M cash vs $4M debt, net cash position |
| Cash Flow | Strong — FCF $14M, 24% margin |
| Efficiency | Critical — ROE -24%, ROA -7.6% |
Ownership (MASS)
| Insider Ownership | +8.75% |
|---|---|
| Institutional Ownership | +89.96% |
| Shares Outstanding | 37.81M |
| Float | 23.94M |
| Short % of Float | +17.92% |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Leadership (MASS)
908 Devices Inc. is led by Kevin J. Knopp (age 52), Co-Founder, CEO, President & Director, per Nexqual as of June 10, 2026 at 02:23 UTC.
| Co-Founder, CEO, President & Director | Kevin J. Knopp (age 52) |
|---|---|
| Co-Founder, Board Advisor & Director | Christopher David Brown (age 50) |
| CFO & Treasurer | Joseph H. Griffith (age 50) |
| Vice President of Corporate Marketing and Communications | Barbara Russo (age 61) |
| Senior Vice President of Sales and Product Marketing | John Kenneweg (age 52) |
Major Backers & Investors (MASS)
Notable institutional backers of 908 Devices Inc. include First Light Asset Management, LLC, AWM Investment Company, Inc., ARK Invest, according to Nexqual as of June 10, 2026 at 02:23 UTC.
Active Investors
| Investor | Stake |
|---|---|
| First Light Asset Management, LLC | 16.06% |
| AWM Investment Company, Inc. | 13.75% |
| ARK Invest | 9.86% |
| First Eagle Investment Management, LLC | 3.6% |
| Needham Investment Management, L.L.C. | 3.28% |
| Needham Funds Inc-Needham Aggressive Growth Fund | 2.45% |
| Granahan Investment Management LLC | 1.84% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 6.91% |
| Vanguard Group | 5.85% |
| Geode Capital | 1.84% |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
From 908 Devices Inc.'s Latest SEC 10-K Filing (filed 2026-03-09)
Key Strengths & Strategy (as disclosed to the SEC)
- 908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications.
- It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SEER | Seer, Inc. | USD 1.69 | ▼ 5.59% |
| PSNL | Personalis, Inc. | USD 9.75 | ▼ 9.3% |
| CDXS | Codexis, Inc. | USD 2.47 | ▼ 3.52% |
| VCYT | Veracyte, Inc. | USD 49.24 | ▲ 1.05% |
| CSTL | Castle Biosciences, Inc. | USD 21.08 | ▲ 0.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:23 UTC. This page is informational and not investment advice.